Membrane-localized activation of glucuronide prodrugs by β-glucuronidase enzymes

@article{Chen2007MembranelocalizedAO,
  title={Membrane-localized activation of glucuronide prodrugs by β-glucuronidase enzymes},
  author={K Chen and T-L Cheng and Y. L. Leu and Zeljko M. Prijovich and C-H Chuang and B M Chen and Steve R Roffler},
  journal={Cancer Gene Therapy},
  year={2007},
  volume={14},
  pages={187-200}
}
Gene-mediated enzyme prodrug therapy (GDEPT) seeks to increase the therapeutic index of anti-neoplastic agents by promoting selective activation of relatively nontoxic drug derivatives at sites of specific enzyme expression. Glucuronide prodrugs are attractive for GDEPT due to their low toxicity, bystander effect in the interstitial tumor space and the large range of possible glucuronide drug targets. In this study, we expressed human, murine and Esherichia coli β-glucuronidase on tumor cells… CONTINUE READING
6 Citations
46 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 46 references

A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapy

  • M de Graaf, TJ Nevalainen, HW Scheeren, HM Pinedo, HJ Haisma, E. Boven
  • Biochem Pharmacol
  • 2004

Similar Papers

Loading similar papers…